Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
46,377,939
-
Number of holders
-
216
-
Total 13F shares, excl. options
-
30,206,509
-
Shares change
-
+1,060,580
-
Total reported value, excl. options
-
$1,132,914,126
-
Value change
-
+$45,004,448
-
Put/Call ratio
-
26%
-
Number of buys
-
105
-
Number of sells
-
-104
-
Price
-
$37.50
Significant Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q1 2023
243 filings reported holding AMPH - Amphastar Pharmaceuticals, Inc. - Common Stock as of Q1 2023.
Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) has 216 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30,206,509 shares
of 46,377,939 outstanding shares and own 65% of the company stock.
Largest 10 shareholders include BlackRock Inc. (6,567,076 shares), FEDERATED HERMES, INC. (3,386,613 shares), VANGUARD GROUP INC (2,651,605 shares), DIMENSIONAL FUND ADVISORS LP (1,917,571 shares), STATE STREET CORP (1,359,495 shares), FULLER & THALER ASSET MANAGEMENT, INC. (811,694 shares), GEODE CAPITAL MANAGEMENT, LLC (759,981 shares), NORTHERN TRUST CORP (649,228 shares), Invesco Ltd. (592,769 shares), and Granite Investment Partners, LLC (536,821 shares).
This table shows the top 216 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.